Ownership history in CITADEL ADVISORS LLC · 53 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in ORTHOFIX MED INC (OFIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 19,545 | +8,645 | +79.3% | 0.00% | $296K | $15.16 |
| 2025 Q3 | REDUCED | 10,900 | -1,143 | -9.5% | 0.00% | $160K | $14.64 |
| 2025 Q2 | REDUCED | 12,043 | -93,452 | -88.6% | 0.00% | $134K | $11.15 |
| 2025 Q1 | ADDED | 105,495 | +104,995 | +20999.0% | 0.00% | $1.7M | $16.31 |
| 2025 Q1 | REDUCED | 500 | -1,700 | -77.3% | 0.00% | $8K | $16.31 |
| 2025 Q1 | ADDED | 2,200 | +1,800 | +450.0% | 0.00% | $36K | $16.31 |
| 2024 Q4 | UNCHANGED | 400 | — | 0% | 0.00% | $7K | $17.46 |
| 2024 Q4 | REDUCED | 400 | -150,043 | -99.7% | 0.00% | $7K | $17.46 |
| 2024 Q4 | ADDED | 150,443 | +150,343 | +150343.0% | 0.00% | $2.6M | $17.46 |
| 2024 Q3 | REDUCED | 100 | -287,556 | -100.0% | 0.00% | $2K | $15.62 |
As of 2025 Q4 — sorted by position size